David S Breslin, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1978 Crompond Rd, Care Mount Medical Pc, Cortlandt Manor, NY 10567 Phone: 914-739-2121 Fax: 914-242-1516 |
Dr. Antoinette Berkeley-gsegnet, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1985 Crompond Rd, Bldg D, Cortlandt Manor, NY 10567 Phone: 914-739-1219 Fax: 914-739-2353 |
Domingo Cp Favale, Urology Medicare: Accepting Medicare Assignments Practice Location: 1985 Crompond Road, Bldg D, Cortlandt Manor, NY 10567 Phone: 914-739-1219 Fax: 914-739-2353 |
Michael J Altamura, M.D. Urology Medicare: Medicare Enrolled Practice Location: 1978 Crompond Rd, Care Mount Medical Pc, Cortlandt Manor, NY 10567 Phone: 914-739-2121 Fax: 914-242-1516 |
Marc D Danziger, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1978 Crompond Rd, Cortlandt Manor, NY 10567 Phone: 914-737-8675 Fax: 914-737-6016 |
News Archive
Professor Matthew Disney of the Department of Chemistry on the Florida campus of The Scripps Research Institute, together with scientists from Mayo Clinic's Florida campus and Johns Hopkins School of Medicine, has been awarded $7.2 million from the National Institute of Neurological Disorders and Stroke of The National Institutes of Health to create new RNA-based treatments for the most common form of amyotrophic lateral sclerosis (ALS), as well as a type of frontotemporal dementia (FTD).
Researchers at the Angiocardioneurology Department of the Neuromed Scientific Institute for Research, Hospitalisation and Health Care of Pozzilli (Italy), have found, in animal models, that the absence of a certain enzyme causes a syndrome resembling the Attention Deficit Hyperactivity Disorder (ADHD).
The Covid-19 pandemic, like many other health crises, has had unequal effects on the U.S. population, with communities of color often hit the hardest.
A new investment fund structured by JPMorgan Chase & Co. (NYSE: JPM) and the Bill & Melinda Gates Foundation will, for the first time, allow individual and institutional investors the opportunity to finance late-stage global health technologies that have the potential to save millions of lives in low-income countries.
› Verified 2 days ago